2Olapade-Olaopa EO,Obamuyide HA,Yisa GT.Management of advanced prostate cancer in Africa.Can J Urol,2008,15:3890-3898.
3Tunn UW,Acar O,Goldschmidt AJ.Effects of androgen deprivation prior to radical prostatectomy in 375 patients.Urol Int,1996,56:6-12.
4Chen M,Hricak H,Kalbhen CL,et al.Hormonal ablation of prostatic cancer:effects on prostate morphology,tumor detection,and staging by endorectal coil MR imaging.Am J Roentgenol,1996,166:1157-1163.
5Gleave ME,Goldenberg SL,Jones EC,et al.Biochemical and pathological effects of 8 months of neoadjuvant androgen withdrawal therapy before radical prostatectomy in patients with clinically confined prostate cancer.J Urol,1996,155:213-219.
6Tunn UW.Neo-adjuvanthormomal therapy of prostate cancer.Urol Res,1997,25 Suppl 2:S57-62.
7Hsu CY,Joniau S,Roskams T,et al.Comparing results after surgery in patients with clinical unilateral T3a prostate cancer treated with or without neoadjuvant androgen-deprivation therapy.BJU Int,2007,99:311-314.
8Pu XY,Wang XH,Wu YL,et al.Comparative study of the impact of 3-versus 8-month neoadjuvant hormonal therapy on outcome of laparoscopic radical prostatectomy.J Cancer Res Clin Oncol,2007,133:555-562.
